AcureOmics AB

AcureOmics was founded in 2008 by Associate Professor Johan Trygg, Professor Torbjörn Lundstedt and Professor Thomas Moritz. The company is a leader in metabolomics and metabolic profiling of autoimmune diseases for instance Rheumatoid Arthritis (RA), diabetes, and Systemic lupus erythematosus (SLE). AcureOmics have also successfully studied drug treatment response and reactions to kidney transplantations. Together with clinicians, biotech companies, patient organizations and universities we develop therapeutic, diagnostic and prognostic biomarkers for more individual-based, personalized healthcare.
In addition to a modern NMR-facility at Umeå University, AcureOmics also have full access to the Swedish national metabolomics platform at the Swedish University of Agricultural Sciences (SLU) in Umeå. Since its launch in 2002, more than 45,000 samples ranging from plasma and cerebrospinal fluid to plants have been analysed resulting in more than 40 research papers. The seven individual instruments available to AcureOmics cover both liquid and gas chromatography (LC and GC) coupled with mass spectrometry (MS).  
Contact persons active in BioMargin

Prof Torbjörn Lundstedt
Dr Johan Trygg